معرفی
Dr. Atefeh Talebi is a Medical Statistician at the British Heart Foundation (BHF) Cardiovascular Research Center, University of Glasgow, specializing in Cardiovascular & Metabolic Health. Her work focuses on statistical methodologies in clinical trials and observational studies, particularly in heart failure, diabetes, and metabolic disorders. She collaborates on large-scale cohort studies like the UK Biobank, analyzing data to develop predictive models for disease outcomes.
Her research interests include the application of machine learning in healthcare, drug efficacy assessments, and risk prediction models for cardiovascular and metabolic conditions. She has contributed to studies on therapies like sacubitril/valsartan and dapagliflozin, evaluating their impacts on patient outcomes such as quality of life and hospitalization rates.
Dr. Talebi’s recent work also explores lifestyle and occupational risk factors for diseases like bladder cancer and gastric cancer metastasis, using advanced statistical techniques. Her publications emphasize evidence-based approaches to improve clinical decision-making and public health strategies.
She secured a grant from Tenovus Scotland (2024) for investigating seasonal variations in cardiovascular hospitalizations using UK Biobank data. Her collaborative projects often involve interdisciplinary teams, leveraging both clinical and epidemiological insights.